2021-03-21
Great Bay Bio Officially Launches AI Enabled Cell Culture Media Development Platform, AlfaMedX
[Hong Kong, March 31, 2021] Great Bay Bio Holdings Limited (hereinafter referred to as “GBB”) is pleased to announce that the company’s self-developed AI-enabled cell culture media development platform, AlfaMedX®, is officially launched. AlfaMedX is crea